The RBP4-induced shift toward type II fibers may contribute to reduced endurance capacity and increased fatigability, potentially exacerbating the physical limitations often observed in metabolic disorders (Schiaffino and Reggiani, 2011; Lin et al., 2005). The gene discussed is RBP4; the disease is metabolic disease.